Skip to main content
. 2024 May 16;13(1):LMT67. doi: 10.2217/lmt-2023-0010

Table 2.

Multivariate regression analysis with interaction terms.

Outcome Subgroup factor Divided standard Numbers of studies HR (95% CI) p-value Heterogeneity Effects model
I2 (%) Phet
OS Country Italy 1 1.98 (1.47–2.67) <0.001 FEM
Turkey 2 1.74 (1.38–2.19) <0.001 0.0 0.385 FEM
USA 2 2.38 (1.66–3.42) <0.001 0.0 0.750 FEM
China 16 1.73 (1.49–2.02) <0.001 62.3 <0.001 REM
Sample size ≥200 13 1.70 (1.47–1.96) <0.001 64.9 0.001 REM
<200 8 2.02 (1.66–2.45) <0.001 14.5 0.317 FEM
SII cut-off value ≥900 5 2.22 (1.86–2.63) <0.001 0.0 0.813 FEM
<900 16 1.65 (1.44–1.88) <0.001 52.4 0.008 REM
Analysis type MVA 20 1.81 (1.59–2.06) <0.001 59.8 <0.001 REM
UVA 1 1.42 (0.90–2.25) 0.135 FEM
PFS Country Italy 1 1.32 (1.05–1.67) 0.019 FEM
Turkey 2 1.73 (1.40–2.13) <0.001 4.2 0.307 FEM
China 6 2.21 (1.55–3.16) <0.001 62.1 0.022 REM
USA 1 1.62 (1.07–2.46) 0.023 FEM
Japan 1 0.38 (0.15–0.96) 0.041 FEM
Sample size ≥200 3 1.69 (1.23–2.32) 0.001 72.9 0.025 REM
<200 8 1.80 (1.27–2.53) 0.001 68.8 0.002 REM
Analysis type MVA 8 1.10 (0.71–1.72) 0.671 70.6 0.033 REM
UVA 3 1.91 (1.64–2.21) <0.001 44.9 0.08 FEM
SII cut-off value ≥900 4 1.38 (0.84–2.26) 0.2 81.0 0.001 REM
<900 7 1.92 (1.49–2.47) <0.001 51.3 0.055 REM

FEM: Fixed-effects model; M: Multivariable; OS: Overall survival; PFS: Progression-free survival; REM: Random-effects model; U: Univariable.